Microvast outlines 2026 production expansion and margin focus as Huzhou Phase 3.2 nears serial launch

Earnings Call Insights: Microvast Holdings, Inc. (MVST) Q4 2025

MANAGEMENT VIEW

* Yang Wu, Founder, Chairman & CEO, highlighted that "Microvast has grown into a global leader in advanced battery technologies with over 890 patents granted or pending and our electrified solutions successfully deployed worldwide." He announced the launch of the 55 amp-hour cell, which merges the high-power performance of the 48 amp-hour cell with the high energy output of the 53.5 amp-hour cell, as well as the next-generation LTO cell for high-power output and ultra-fast charging, targeting rail, tram, specialty vehicles, and AGVs.
* Wu stated, "We are thrilled to achieve another year of record annual revenue of $427.5 million, representing a 12.6% year-over-year increase." He noted that margin was impacted by an inventory impairment charge, but emphasized industry-leading gross margin and strong fundamentals despite revenue landing just below guidance due to regulatory shifts in Korea and customer ramp-up delays.
* Wu described the EMEA region’s momentum and anticipated additional capacity in APAC through the Huzhou Phase 3.2 expansion, with serial production expected in 2026.
* Rodney Worthen, Chief Financial Officer, reported, "Microvast achieved record annual revenue in 2025, reaching $427.5 million, a 12.6% increase compared to the $379.8 million in 2024. This growth was primarily due to a year-over-year increase in our sales volume, approximately 16.5% or 266 megawatt hours."
* Worthen added that a $32.5 million inventory impairment charge related to specialized ESS components negatively impacted gross margin by 7.6 percentage points, but underlying performance reflected improved product mix and manufacturing efficiencies.

OUTLOOK

* Wu asserted, "As we look ahead to 2026, we are entering a phase of business defined by strategic agility. While we expect continued revenue growth, our 2026 profile is being carefully assessed against a backdrop of evolving tariff structures and shifting geopolitical dynamics."
* The company’s strategy is anchored on three pillars: innovate, expand, and capture, with a focus on synchronizing production increases with accelerating customer demand and aiming to reach a cash flow positive state.
* Wu highlighted, "We are on track to achieve serial production in 2026. Phase 3.2 is a critical milestone that brings online the capacity necessary to meet upcoming demand for our next-generation cell technology."
* The company aims to protect margins, diversify its customer base, and reach production ramp-up milestones in 2026.

FINANCIAL RESULTS

* Annual gross profit reached $122.1 million, with a gross margin of 28.6% compared to 31.5% in 2024. Operating profit was $6.98 million, with a GAAP net loss of $29.2 million and a non-GAAP adjusted net profit of $13 million.
* Non-GAAP adjusted EBITDA was $44.7 million, a significant improvement over a negative $44.8 million in 2024.
* U.S. revenue grew 173% year-over-year to $39.3 million, driven by customers advancing deliveries due to tariff uncertainty. EMEA revenue increased 13% to $211.9 million, while APAC revenue saw a slight decline to $176.3 million.
* Net positive operating cash flow of $75.9 million was achieved, with ending cash, cash equivalents, and restricted cash at $169.2 million.

Q&A

* NOT_APPLICABLE: The transcript did not include a Q&A session or any analyst questions and management responses.

SENTIMENT ANALYSIS

* The absence of analyst questions precludes direct assessment of analyst sentiment.
* Management tone during prepared remarks was confident and future-focused, marked by statements such as "We are thrilled to achieve another year of record annual revenue" and emphasis on strategic milestones and operational execution.
* Compared to the previous quarter, management continues to project confidence but places greater focus on navigating regulatory and geopolitical headwinds, especially regarding Korea and tariffs. The discussion of inventory impairment and near-term headwinds was direct but balanced by highlighting margin protection and production expansion.

QUARTER-OVER-QUARTER COMPARISON

* The previous quarter’s outlook affirmed annual revenue guidance in the range of $450 million to $475 million and raised the full year gross margin target; the current quarter reported actual annual revenue of $427.5 million, slightly below prior guidance due to regulatory and ramp-up challenges.
* The Huzhou Phase 3.2 expansion remains the centerpiece of operational strategy, now transitioning from installation to trial production, with serial production targeted for 2026.
* Management’s focus has sharpened on margin protection, cash flow, and high-barrier market segments, reflecting a more cautious tone regarding macroeconomic and geopolitical factors than in the previous quarter.
* Analysts’ questions are unavailable, but the prepared remarks focus has shifted from aggressive growth to strategic agility, efficiency, and response to external risks.

RISKS AND CONCERNS

* Management cited evolving regulatory changes in Korea and customer platform ramp-up delays in EMEA as factors impacting revenue.
* The company absorbed a $32.5 million inventory impairment charge due to specialized ESS components.
* Wu emphasized strategic agility to navigate "evolving tariff structures and shifting geopolitical dynamics."
* Mitigation strategies include focusing on high-margin deliveries, synchronizing production with demand, expanding capacity, and operational discipline.

FINAL TAKEAWAY

Microvast management emphasized that despite regulatory and operational challenges in 2025, the company delivered record revenue and demonstrated a significant shift toward profitability. The Huzhou Phase 3.2 expansion stands as the primary catalyst for 2026, with serial production anticipated to support next-generation product launches and margin integrity. The company is committed to margin protection, disciplined expansion, and targeting high-value market segments while closely monitoring macroeconomic and geopolitical developments. Management remains focused on executing production ramp-up, diversifying its customer base, and maintaining operational efficiency to drive long-term shareholder value.

Read the full Earnings Call Transcript [https://seekingalpha.com/symbol/mvst/earnings/transcripts]

MORE ON MICROVAST HOLDINGS

* Microvast Holdings, Inc. 2025 Q4 - Results - Earnings Call Presentation [https://seekingalpha.com/article/4882932-microvast-holdings-inc-2025-q4-results-earnings-call-presentation]
* Microvast Holdings, Inc. (MVST) Q4 2025 Earnings Call Prepared Remarks Transcript [https://seekingalpha.com/article/4882918-microvast-holdings-inc-mvst-q4-2025-earnings-call-prepared-remarks-transcript]
* Microvast Holdings Non-GAAP EPS of -$0.11 misses by $0.13, revenue of $96.4M misses by $34.98M [https://seekingalpha.com/news/4564996-microvast-holdings-non-gaap-eps-of-0_11-misses-by-0_13-revenue-of-96_4m-misses-by-34_98m]
* Seeking Alpha’s Quant Rating on Microvast Holdings [https://seekingalpha.com/symbol/MVST/ratings/quant-ratings]
* Historical earnings data for Microvast Holdings [https://seekingalpha.com/symbol/MVST/earnings]